Advanced International Breast Cancer Course - (AIBCC) 17th MEET THE PROFESSOR For information www.accmed.org
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
17th MEET THE PROFESSOR Advanced International Breast Cancer Course (AIBCC) For information www.accmed.org
Aims Mortality from breast cancer is declining in most countries thanks to effective screening programs, early diagnosis, molecular characterization of the different subtypes and biology-driven treatments. A multidisciplinary management of breast cancer patients is therefore the key to success and a breast multidisciplinary team should include - besides the “classic” clinical specialties - pathologists, molecular biologists and geneticists. Furthermore, the availability of multiple diagnostic and therapeutic choices, the increasing costs of new technologies and drugs and the issue of sustainability represent a new challenge for socially- responsible clinicians. With this goal in mind, the Programme includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes and issues of sustainability and drug access across countries. Addressed to Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists, pharmacists, and nurses.
Thursday, September 30th
International speakers will be connected from various countries and local speakers will be present
at the meeting venue.
Introduction
14.45 to the Conference
Pier Franco Conte, Gabriel N. Hortobagyi, Valentina Guarneri,
Philip Poortmans
SESSION I
Chairpersons: Hesham Ahmed Gaballah Elghazaly, Pier Franco Conte
15.20 besity and cancer
O
Roberto Vettor
Management
15.20 of women BRCA1/2
and other predisposition gene mutations
Shani Paluch-Shimon
15.40 Axillary dissection: still an option?
Elefterios Mamounas
16.00 Hot topics in breast cancer RT
Philip Poortmans
16.20 Clinical impact of genomics in BC
Aleix Prat
16.40 PIK3CA testing: from technical aspects to clinical application
Sybille Loibl
17.00 Prognostic signatures to guide treatment decision
Gabriel N. Hortobagyi
17.20 Q&A
17.30 Adjourn
Friday, October 1st
International speakers will be connected from various countries and local speakers will be present
at the meeting venue.
SESSION II –MULTIDISCIPLINARY TUMOR BOARD
Chairperson: Pier Franco Conte, Valentina Guarneri
10.00
Clinical case 1: Omission of RT in elderly patients
with low-risk tumor
Franco Berti
10.20 linical case 2: cT1c, cN0 HER2+tumor: neo vs adjuvant
C
(option to escalate or de-escalate therapy)
Cristina Falci
10.40
Clinical case 3: Post-neoadjuvant therapy in patients with RD
(stressing the concept of RCB and characterization of RD)
Federica Miglietta
11.00
Clinical case 4: oligometastatic disease
Grazia Vernaci
11.20 linical case 5: Brain mets
C
Gaia Griguolo
11.40
Clinical case 6: when to stop active therapy
Carlo Alberto Giorgi
12.00 Lunch
SESSION III
Chairpersons: Jacek Jassem, Valentina Guarneri
Adjuvant
14.30 CDK4/6i for HR+ disease:
reconciling data from randomized trials
Valentina GuarneriEarly
14.50 BRCAm tumors: PARPi are coming!
Pier Franco Conte
Neoadjuvant
15.10 therapy for early breast cancer:
beyond the pCR dogma
Pier Franco Conte
Immunotherapy
15.30 for early TNBC: hopes and hypes
Hope Rugo
15.50 Q&A
Antibody
16.10 Drug Conjugates for BC
Frederik Marmè
Targeting
16.30 unconventional pathways in Luminal BC
Maria Vittoria Dieci
Treatment
16.50 algorithm for HR+/HER2- ABC
Stephen Johnston
Treatment
17.10 algorithm for HER2+ ABC
Sandra Swain
Treatment
17.30 algorithm and new options for TN ABC
Miguel Martin
17.50 Q&A
18.10 AdjournAccess Mode To ensure compliance with the health event provisions relating to Covid-19, AIBCC 2021 will be held both as in-class course and as a live webinar. When registering, it is necessary to select the desired participation method, until exhaustion of available places. Registration for the activity can only take place online, no registrations will be accepted at the congress venue. AccMed reserves the right to carry out the event exclusively in digital mode if the situation of the health emergency from Covid-19 makes it necessary. In this case, AccMed will be responsible for informing speakers and participants of the change in the way the event is going to be held. Live webinar The Live Webinar will allow participants to attend to AIBCC 2021 from anywhere in the world. The Live Webinar, with the participation of speakers connected from various countries, is addressed to both Italian and foreign participants. The official language of the course is English. No simultaneous translation will be provided. To follow the webinar, participants will need a good quality internet connection and a device (PC, Smartphone, Tablet) capable of running a recent Internet browser (e.g. any updated version of Chrome or Firefox). In-Class Course The in-class course will take place at the venue specified underneath. Please note that due to COVID mitigation measures, the availability of places for the in-presence course is limited. The in-class course, with the participation of speakers connected from various countries and local speakers present at the meeting venue, is addressed primarily to Italian participants. The official language of the course is English. No simultaneous translation will be provided.
CME Webinar live Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-324301): 12 CME points. Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease. The credit certification for the webinar is subject to: - Professions/specializations should correspond to those which have been accredited for CME - attendance at the 100% of the async distance learning and webinar live on the platform fad.accmed.org; - the completion of the Meeting evaluation online form; - completion of the final test (at least 75% of correct answers). 5 attempts admitted. The test and the meeting evaluation form must be completed within 3 days from the end of the event. CME In-Class Course Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-324769): 8 CME points. The credit certification for the webinar is subject to: - Professions/specializations should correspond to those which have been accredited for CME; - attendance at the 90% of the meeting; - completion of the meeting evaluation online form; - completion of the final test (at least 75% of correct answers). 1 attempt admitted. The test and the meeting evaluation form must be completed within 3 days from the end of the event. Training objective: professional and technical content (knowledge and skills) specific to each profession, specialisation and highly specialised activity. Rare disease.
Directors
Pier Franco Conte Gabriel N. Hortobagyi
Division of Medical Oncology 2 Department of Breast Medical Oncology
Istituto Oncologico Veneto IRCCS The University of Texas -
Department of Surgery, Oncology and MD Anderson Cancer Center
Gastroenterology Houston (USA)
University of Padova (I)
Philip Poortmans
Valentina Guarneri Former president of ESTRO and of ECCO
Division of Medical Oncology 2 Department of Radiation Oncology
Istituto Oncologico Veneto IRCCS Iridium Netwerk
Department of Surgery, Oncology and University of Antwerp
Gastroenterology Wilrijk-Antwerp (B)
University of Padova (I)
Scientific Committee
Hesham Ahmed Gaballah Elghazaly Miguel Martin
Department of Clinical Oncology Medical Oncology Service
and nuclear medicine Hospital Universitario Gregorio Marañon
University of Ainshams Madrid (E)
Cairo (EG)
Stefania Migliuolo
Jacek Jassem Europa Donna Italia
Department of Oncology and Radiotherapy Milan (I)
Medical University of Gdansk (PL)
Fedro Alessandro Peccatori
Stephen Johnston Department of Medical Oncology
NIHR Biomedical Research Centre for Cancer European Institute of Oncology (IEO)
Royal Marsden NHS Foundation Milan (I)
Trust & Institute of Cancer Research
London (UK) Aleix Prat
Medical Oncology Department
Sibylle Loibl Hospital Clinic
German Breast Group Barcellona (E)
University of Frankfurt (D)
Sandra M. Swain
Eleuterios Mamounas Research Development
Comprehensive Breast Program Georgetown University Medical Center
MD Anderson Cancer Center Orlando Washington (USA)
Orlando (F)Speakers
Franco Berti Valentina Guarneri
Department of Radiation Oncology Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Department of Surgery, Oncology and
Gastroenterology Gastroenterology
University of Padova (I)
University of Padua (I)
Gabriel N. Hortobagyi
Pier Franco Conte
Department of Breast Medical Oncology
Division of Medical Oncology 2
The University of Texas -
Istituto Oncologico Veneto IRCCS
MD Anderson Cancer Center
Department of Surgery, Oncology and
Houston (USA)
Gastroenterology
University of Padova (I)
Stephen Johnston
NIHR Biomedical Research Centre for Cancer
Maria Vittoria Dieci
Royal Marsden NHS Foundation Trust &
Division of Medical Oncology 2
Institute of Cancer Research
Istituto Oncologico Veneto IRCCS
London (UK)
Department of Surgery, Oncology and
Gastroenterology
Sibylle Loibl
University of Padova (I)
German Breast Group
University of Frankfurt (D)
Cristina Falci
Division of Medical Oncology 2
Eleuterios Mamounas
Istituto Oncologico Veneto IRCCS
Comprehensive Breast Program
Department of Surgery, Oncology and
MD Anderson Cancer Center Orlando
Gastroenterology
Orlando (F)
University of Padua (I)
Frederik Marmè
Carlo Alberto Giorgi
National Center for Tumor Diseases (NCT)
Division of Medical Oncology 2
University of Heidelberg (DE)
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and
Miguel Martin
Gastroenterology
Medical Oncology Service
University of Padua (I)
Hospital Universitario Gregorio Marañon
Madrid (E)
Gaia Griguolo
Division of Medical Oncology 2
Federica Miglietta
Istituto Oncologico Veneto IRCCS
Division of Medical Oncology 2
Department of Surgery, Oncology and
Istituto Oncologico Veneto IRCCS
Gastroenterology
Department of Surgery, Oncology and
University of Padua (I)
Gastroenterology
University of Padua (I)Shani Paluch-Shimon Sandra M. Swain Sharett Institute of Oncology Research Development Hadassah University Hospital Georgetown University Medical Center Jerusalem (IL) Washington (USA) Philip Poortmans Grazia Vernaci Former president of ESTRO and of ECCO Division of Medical Oncology 2 Department of Radiation Oncology Istituto Oncologico Veneto IRCCS Iridium Netwerk Department of Surgery, Oncology and University of Antwerp Gastroenterology Wilrijk-Antwerp (B) University of Padua (I) Aleix Prat Roberto Vettor Medical Oncology Department Division of Internal Medicine Hospital Clinic University of Padova (I) Barcellona (E) Hope Rugo UCSF Carol Franc Buck Breast Care Center Breast Oncology Clinical Trials Program San Francisco (USA)
Registration
€ 180,00
€ 100,00 for graduate students and nurses
Online registration at http://meettheprofessor.accmed.org before 20 September;
the application will be completed only after the payment of the registration fee.
CANCELLATION
In order to cancel please give advise with a written communication to Accademia
Nazionale di Medicina within 10 days from the beginning. A 70% of the
registration fee will be returned. Any cancellation after that deadline will not be
reimbursed.
Meeting venue In-Class Course
Four Points by Sheraton
Corso Argentina, 5
Padova
Under 40
Free admission is available for a few people “under 40”.
Registration forms will be accepted on a first-come, first-served basis until
spaces will be full.
The Organization Secretariat will confirm the registration by email.
Un’azione sostenibile a favore della formazione
Iscrizione gratuita UNDER 40 fino a esaurimento postiSupported by unrestricted educational grants from GOLD SPONSOR SILVER SPONSOR BRONZE SPONSOR CONTRIBUTORS
With the patronage of
INSTITUTIONS
Comune di Padova
SCIENTIFIC SOCIETIESOrganizer
ACCADEMIA NAZIONALE
DI MEDICINA
General Manager: Stefania Ledda
www.accmed.org
Information:
http://meettheprofessor.accmed.org
Ph. 0039 51 0569163 – 51 6360080
info.bologna@accmed.org
Organizing Partner
Forum Service
Via Martin Piaggio, 17/8
16122 GenovaYou can also read
